Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of LGI1 in Autosomal Dominant Lateral Temporal Lobe Epilepsy
Site Specific Mutagenesis in the Env Gene of Rsv
Semiparametric Bayesian Methods for Survival Data
Fluid Dynamics in Transparent Natural Blood Vessels
Pharmacological Studies of Central Synaptic Transmission
Recently added grants:
A novel role of fascin in cancer metastasis
Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
Host-Microbiota Interactions in Crohn's Disease-associated Spondyloarthritis
Michigan MoTrPAC Chemical Analysis Site (MiCAS)
Crosslinking Action of Chlorpyrifos Oxon as Mechanism of Chronic Illness
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-002
Application #
6688654
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant